Depression treatment therapy Market Trends, Size, Competitive Analysis and Forecast - 2018-2023

Depression treatment is facing stiff decline. The depression treatment market is expected to grow at low CAGR of 2.1% for the forecasted period of 2018-2023. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and the growing strength of generic drug manufacturers. The patent cliff has caused a decline in revenues ranging from a few million dollars to billions. The patent expiration and generic drug manufacturers gaining the license to manufacturers have forced many branded drug manufacturers to either stop their R&D or to reduce budgets. There is a very limited number of new drugs in the pipeline. The decline in revenues is majorly due to falling in the price of once-expensive drugs by over 50-90%. Volume shipment is still high and increasing especially in emerging markets.

Request a free sample of our report on Depression treatment therapy Market: https://www.omrglobal.com/request-sample/depression-treatment-market

However, markets for therapies using medical devices such as Vagus nerve stimulation, deep brain stimulation, and smartphones are rising. The devices market is expected to grow at a CAGR of 9.2%. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders are also driving the market.

A full report of Depression treatment therapy Market Is available at https://www.omrglobal.com/industry-reports/depression-treatment-market

Depression treatment therapy Market segmentation

By depression type
• Seasonal affective disorder (sad)
• Major depression
• Dysthymia disorder
• Postpartum depression
• Atypical depression
• Psychotic depression
• Bipolar disorder

By drugs type
• Selective serotonin reuptake inhibitors
o Fluoxetine (prozac)
o Sertraline (zoloft)
o Escitalopram (lexapro)
o Others ssris

• Atypical antidepressants
o Bupropion (wellbutrin)
o Duloxetine (cymbalta)
o Venlafaxine (effexor)
o Desvenlafexine (pristiq)
o Others atypical antidepressants

• Tricyclic antidepressants

By depression treatment device
• Transcranial magnetic
• Deep brain stimulator
• Virtual reality therapy
• Vagus nerve simulator
• Smart phone applications
• Others devices

Competitive landscape
• Market share analysis
• Key company analysis

Regional analysis
• North america
o United states
o Canada
o Rest of north america

• Europe
o United kingdom
o France
o Germany
o Italy
o Spain
o Rest of europe

• Asia pacific
o India
o China
o Japan
• Rest of the world

Company profiles
• Abbott laboratories
• Allergan plc
• Astrazeneca
• Brain resource company (brc)
• Brainsway ltd.
• Bristol myers squibb
• Cyberonics, inc
• Electromedical products international, inc.
• Eli lilly and company
• Johnson & johnson

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/depression-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.